Business Context and Reporting Period
Company: Firefly Neuroscience, Inc. (AIFF)
Filing Type: Form 8-K (Current Report)
Date of Report: June 25, 2026
Reporting Period: Specific event date of June 25, 2026
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on the termination of a specific contractual agreement.
Material Changes
- Termination of Material Definitive Agreement: The Company and an accredited investor mutually agreed to terminate a Securities Purchase Agreement dated May 6, 2026.
- Original Agreement Details: The terminated agreement allowed for the issuance and sale of up to 666,667 units at $1.50 per unit, with potential aggregate gross proceeds of up to $1,000,000.
- Effective Date: The termination is effective as of June 25, 2026.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future outlook, or specific risk factors beyond the cessation of the previously announced capital raise. The termination was executed pursuant to Section 5.3 of the Purchase Agreement.
Investor Verification Checklist
- Verify the status of the Company's current cash position following the termination of the $1,000,000 potential capital raise.
- Review the May 12, 2026 Form 8-K to understand the original terms and conditions of the terminated Purchase Agreement.
- Confirm if the Company has announced alternative financing plans to replace the terminated transaction.
- Check for any subsequent filings regarding the Company's liquidity needs or operational runway.